Skip to main content

Table 2 Predictors of cervical cancer screening programme period coverage in Estonia, 2009–2018

From: Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study

  WLWH: HIV specific screening
(595/2448) 24.31%
WLWH: organised screening
(266/1914) 13.90%
General population women: organised screening
(1210/6365) 19.01%
N (% covered) OR (95% CI) AOR (95% CI) N (% covered) OR (95% CI) AOR (95% CI) N (% covered) OR (95% CI) AOR (95% CI)
Region
 Capital 1009 (31.32) 1 1 788 (13.71) 1 1 2618 (20.02) 1 1
 North-East 1214 (27.76) 0.704 (0.581,0.851) 0.705 (0.581,0.855) 970 (14.85) 0.999 (0.759,1.317) 1.007 (0.764,1.330) 3273 (18.70) 0.920 (0.808,1.048) 0.918 (0.806,1.046)
 Else 225 (27.11) 0.662 (0.473,0.915) 0.767 (0.544,1.071) 156 (8.97) 0.560 (0.298,0.978) 0.610 (0.324,1.070) 474 (15.61) 0.739 (0.563,0.959) 0.732 (0.557,0.951)
Age groups
 16–19 114 (34.21) 1 1       
 20–29 1335 (32.96) 0.937 (0.622,1.424) 0.930 (0.618,1.419) 1031 (16.39) 1 1 3879 (18.72) 1 1
 30–39 563 (28.42) 0.691 (0.448,1.078) 0.686 (0.444,1.071) 563 (11.19) 0.617 (0.449,0.838) 0.621 (0.452,0.843) 1587 (17.77) 0.939 (0.805,1.091) 0.948 (0.813,1.103)
 40–49 222 (23.87) 0.523 (0.315,0.868) 0.521 (0.314,0.866) 222 (10.36) 0.554 (0.340,0.865) 0.565 (0.347,0.883) 647 (23.65) 1.344 (1.099,1.635) 1.364 (1.115,1.660)
 50–55 98 (12.25) 0.204 (0.095,0.411) 0.206 (0.096,0.416) 98 (11.22) 0.563 (0.278,1.038) 0.586 (0.289,1.083) 252 (19.44) 1.047 (0.751,1.433) 1.083 (0.776,1.484)
 56+ 116 (8.62) 0.136 (0.060,0.281) 0.135 (0.060,0.281)       
Insured (uninsured if it occurs ever during the follow-up) (baseline is insured) 1704 (34.04)
744 (18.01)
1
0.426 (0.343,0.525)
1
0.331 (0.264,0.412)
1339 (15.53)
575 (10.09)
1
0.610 (0.444,0.826)
1
0.545 (0.394,0.745)
6355 (19.02)
10 (10.00)
1
0.4729 (0.026,2.520)
1
0.477 (0.026,2.545)
Stage at index visit (n %)
 Clinical latency 1955 (29.67) 1 1 1548 (13.44) 1 1    
 Acute 87 (39.08) 1.340 (0.851,2.085) 1.444 (0.908,2.271) 69 (23.19) 1.794 (0.974,3.136) 1.993 (1.073,3.523)    
 AIDS 382 (24.35) 0.689 (0.531,0.887) 0.874 (0.666,1.138) 278 (14.03) 1.005 (0.686,1.441) 1.198 (0.811,1.734)    
 Unknown 24 (29.17) 0.885 (0.338,2.085) 1.069 (0.399,2.602) 19 (15.79) 1.178 (0.272,3.586) 1.331 (0.304,4.131)    
AIDS dgn at any time of follow-up (baseline is AIDS not diagnosed) 1383 (31.67)
483 (27.54)
1
0.874 (0.690,1.102)
1
0.879 (0.691,1.114)
1066 (14.92)
400 (10.75)
1
0.708 (0.489,1.006)
1
0.678 (0.466,0.966)
   
HIV care retention (yes: n %) (baseline is not retained) 1691 (25.43)
757 (37.52)
1
1.751 (1.453,2.108)
1
1.972 (1.615,2.410)
1324 (14.50)
590 (12.54)
1
0.824 (0.614,1.095)
1
0.939 (0.688,1.273)
   
Drug abuse (yes: n, %) (baseline is no drug abuse) 2088 (31.37)
360 (16.39)
1
0.517 (0.380,0.693)
1
0.459 (0.336,0.618)
1624 (14.84)
290 (8.62)
1
0.600 (0.379,0.914)
1
0.543 (0.342,0.830)
6360 (19.03)
5 (0.00)
1
0 (−)
1
0 (−)
HCV infection (yes: n %) baseline is no HCV 1532 (31.27)
916 (25.66)
1
0.868 (0.718,1.048)
1
0.754 (0.619,0.916)
1164 (14.26)
750 (13.33)
1
0.998 (0.759,1.307)
1
0.844 (0.637,1.115)
6355 (18.98)
10 (40.00)
1
3.450 (0.845,13.217)
1
3.500 (0.856,13.418)
Drug abuse or HCV co-infection 1448 (32.46)
1000 (24.40)
1
0.780 (0.646,0.940)
1
0.683 (0.562,0.828)
1092 (15.11)
822 (12.28)
1
0.856 (0.651,1.122)
1
0.732 (0.552,0.965)
6353 (18.98)
12 (33.33)
1
2.703 (0.682,9.567)
1
2.751 (0.693,9.751)